Sager, Philip T.

Evolution of strategies to improve preclinical cardiac safety testing

Gintant, G., Sager, P. T., & Stockbridge, N. (2016) · Nature Reviews Drug Discovery

Cardiac electrophysiology and arrhythmiasAnimal testing and alternatives

Cited by 407

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

Laverty, H., Benson, C., Cartwright, E., Cross, M., Garland, C., Hammond, T., Holloway, C., McMahon, N., Milligan, J., Park, B., et al. (2011) · British Journal of Pharmacology

Animal testing and alternativesCardiac electrophysiology and arrhythmias

Cited by 363

Cardiovascular Safety During and After Use of Phentermine and Topiramate

Ritchey, M. E., Harding, A., Hunter, S., Peterson, C., Sager, P. T., Kowey, P. R., Nguyen, L., Thomas, S., Cainzos-Achirica, M., Rothman, K. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism

Pharmacology and Obesity TreatmentPharmacovigilance and Adverse Drug Reactions

Cited by 42

The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment

Abi-Gerges, N., McMahon, C., Vargas, H., Sager, P., Chui, R., Stevens, D., Davila, J., Schaub, J. R., Wu, J. C., del Rio, C., et al. (2019) · Journal of Pharmacological and Toxicological Methods

Animal testing and alternativesCardiac electrophysiology and arrhythmias

Cited by 3